Jupiter Neurosciences Files Q1 2025 10-Q
Ticker: JUNS · Form: 10-Q · Filed: 2025-05-15T00:00:00.000Z
Sentiment: neutral
Topics: 10-Q, pharmaceuticals, quarterly-report
TL;DR
JUPITER NEUROSCIENCES (JUPITER) filed its Q1 2025 10-Q. No major financial changes reported yet.
AI Summary
Jupiter Neurosciences, Inc. filed its quarterly report for the period ending March 31, 2025. The company, formerly known as Jupiter Orphan Therapeutics, Inc., is incorporated in Delaware and operates in the pharmaceutical preparations sector. Its principal executive offices are located in Jupiter, Florida.
Why It Matters
This filing provides investors with an update on Jupiter Neurosciences' financial performance and operational status for the first quarter of 2025, crucial for understanding the company's trajectory in the pharmaceutical sector.
Risk Assessment
Risk Level: low — The filing is a standard quarterly report with no immediately apparent significant financial distress or major strategic shifts indicated.
Key Numbers
- 2834 — SIC Code (Standard Industrial Classification for Pharmaceutical Preparations, indicating the company's industry.)
- 001-41265 — SEC File Number (The SEC file number assigned to Jupiter Neurosciences, Inc.)
Key Players & Entities
- JUPITER NEUROSCIENCES, INC. (company) — Filer of the 10-Q report.
- Jupiter Orphan Therapeutics, Inc. (company) — Former name of Jupiter Neurosciences, Inc.
- 1001 NORTH US HWY 1 (location) — Street address for Jupiter Neurosciences' business and mailing address.
- JUPITER, FL (location) — City and State for Jupiter Neurosciences' business and mailing address.
- 20250331 (date) — Conformed period of report for the 10-Q filing.
FAQ
What is the reporting period for this 10-Q filing?
The conformed period of report is March 31, 2025.
What was Jupiter Neurosciences, Inc. formerly known as?
The company was formerly known as Jupiter Orphan Therapeutics, Inc., with a name change date of July 13, 2016.
Where is Jupiter Neurosciences, Inc. located?
The company's business and mailing address is 1001 NORTH US HWY 1, SUITE 504, JUPITER, FL 33477.
What is the Standard Industrial Classification (SIC) code for Jupiter Neurosciences, Inc.?
The SIC code is 2834, which corresponds to Pharmaceutical Preparations.
When was this 10-Q form filed?
This 10-Q form was filed on May 15, 2025.
From the Filing
0001641172-25-010990.txt : 20250515 0001641172-25-010990.hdr.sgml : 20250515 20250515163124 ACCESSION NUMBER: 0001641172-25-010990 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 56 CONFORMED PERIOD OF REPORT: 20250331 FILED AS OF DATE: 20250515 DATE AS OF CHANGE: 20250515 FILER: COMPANY DATA: COMPANY CONFORMED NAME: JUPITER NEUROSCIENCES, INC. CENTRAL INDEX KEY: 0001679628 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences EIN: 474828381 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-41265 FILM NUMBER: 25954181 BUSINESS ADDRESS: STREET 1: 1001 NORTH US HWY 1 STREET 2: SUITE 504 CITY: JUPITER STATE: FL ZIP: 33477 BUSINESS PHONE: (561) 406-6154 MAIL ADDRESS: STREET 1: 1001 NORTH US HWY 1 STREET 2: SUITE 504 CITY: JUPITER STATE: FL ZIP: 33477 FORMER COMPANY: FORMER CONFORMED NAME: Jupiter Orphan Therapeutics, Inc. DATE OF NAME CHANGE: 20160713 10-Q 1 form10-q.htm 10-Q false Q1 --12-31 0001679628 0001679628 2025-01-01 2025-03-31 0001679628 2025-05-14 0001679628 2025-03-31 0001679628 2024-12-31 0001679628 us-gaap:RelatedPartyMember 2025-03-31 0001679628 us-gaap:RelatedPartyMember 2024-12-31 0001679628 us-gaap:SeriesAPreferredStockMember 2025-03-31 0001679628 us-gaap:SeriesAPreferredStockMember 2024-12-31 0001679628 2024-01-01 2024-03-31 0001679628 us-gaap:CommonStockMember 2024-12-31 0001679628 us-gaap:AdditionalPaidInCapitalMember 2024-12-31 0001679628 us-gaap:RetainedEarningsMember 2024-12-31 0001679628 us-gaap:CommonStockMember 2023-12-31 0001679628 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0001679628 us-gaap:RetainedEarningsMember 2023-12-31 0001679628 2023-12-31 0001679628 us-gaap:CommonStockMember 2025-01-01 2025-03-31 0001679628 us-gaap:AdditionalPaidInCapitalMember 2025-01-01 2025-03-31 0001679628 us-gaap:RetainedEarningsMember 2025-01-01 2025-03-31 0001679628 us-gaap:CommonStockMember 2024-01-01 2024-03-31 0001679628 us-gaap:AdditionalPaidInCapitalMember 2024-01-01 2024-03-31 0001679628 us-gaap:RetainedEarningsMember 2024-01-01 2024-03-31 0001679628 us-gaap:CommonStockMember 2025-03-31 0001679628 us-gaap:AdditionalPaidInCapitalMember 2025-03-31 0001679628 us-gaap:RetainedEarningsMember 2025-03-31 0001679628 us-gaap:CommonStockMember 2024-03-31 0001679628 us-gaap:AdditionalPaidInCapitalMember 2024-03-31 0001679628 us-gaap:RetainedEarningsMember 2024-03-31 0001679628 2024-03-31 0001679628 us-gaap:CommonStockMember 2024-12-01 2024-12-31 0001679628 us-gaap:CommonStockMember 2024-01-01 2024-12-31 0001679628 JUNS:CommonStockOptionsMember 2025-01-01 2025-03-31 0001679628 JUNS:CommonStockOptionsMember 2024-01-01 2024-12-31 0001679628 JUNS:UnvestedRestrictedStockMember 2025-01-01 2025-03-31 0001679628 JUNS:UnvestedRestrictedStockMember 2024-01-01 2024-12-31 0001679628 us-gaap:WarrantMember 2025-01-01 2025-03-31 0001679628 us-gaap:WarrantMember 2024-01-01 2024-12-31 0001679628 2024-01-01 2024-12-31 0001679628 srt:ChiefExecutiveOfficerMember 2025-03-31 0001679628 srt:ChiefExecutiveOfficerMember 2024-12-31 0001679628 us-gaap:EmployeeStockOptionMember 2024-03-15 2024-03-15 0001679628 us-gaap:EmployeeStockOptionMember 2024-03-15 0001679628 us-gaap:RestrictedStockUnitsRSUMember 2024-03-15 0001679628 2024-03-15 2024-03-15 0001679628 us-gaap:RestrictedStockUnitsRSUMember 2024-03-15 2024-03-15 0001679628 us-gaap:RelatedPartyMember 2024-03-31 0001679628 JUNS:EmploymentAgreementsMember 2025-03-31 0001679628 JUNS:EmploymentAgreementsMember 2024-12-31 0001679628 JUNS:ConvertibleDebtOneMember 2021-12-31 0001679628 JUNS:ConvertibleDebtOneMember 2021-08-01 2021-12-31 0001679628 JUNS:ConvertibleDebtOneMember us-gaap:IPOMember 2021-12-31 0001679628 JUNS:ConvertibleDebtOneMember 2024-01-31 0001679628 JUNS:ConvertibleDebtOneMember 2024-12-04 2024-12-04 0001679628 JUNS:ConvertibleDebtOneMember 2024-12-04 0001679628 JUNS:SeniorSecuredNoteConvertibleDebtTwoMember 2022-04-01 2022-04-30 0001679628 JUNS:SeniorSecured